Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Non Operating Investment Income: 2016-2017

Historic Non Operating Investment Income for Aytu Biopharma (AYTU) over the last 2 years, with Jun 2017 value amounting to -$61,519.

  • Aytu Biopharma's Non Operating Investment Income was N/A to $230,936 in Q2 2017 from the same period last year, while for Jun 2017 it was $169,417, marking a year-over-year change of. This contributed to the annual value of -$61,519 for FY2017, which is 93.67% up from last year.
  • According to the latest figures from FY2017, Aytu Biopharma's Non Operating Investment Income is -$61,519, which was up 93.67% from -$971,629 recorded in FY2016.
  • Aytu Biopharma's Non Operating Investment Income's 5-year high stood at -$61,519 during FY2017, with a 5-year trough of -$971,629 in FY2016.
  • In the last 2 years, Aytu Biopharma's Non Operating Investment Income had a median value of -$516,574 in 2016 and averaged -$516,574.
  • Data for Aytu Biopharma's Non Operating Investment Income shows a peak YoY soared of 93.67% (in 2017) over the last 5 years.
  • Yearly analysis of 2 years shows Aytu Biopharma's Non Operating Investment Income stood at -$971,629 in 2016, then surged by 93.67% to -$61,519 in 2017.